Clopidogrel Bests Aspirin for Secondary Prevention of ASCVD MD Bureau1 April 2022 10:45 AM ISTAntiplatelet therapy is the cornerstone for the prevention and treatment of atherothrombosis. Aspirin is the most widely used antiplatelet agent for...
Bariatric surgery tied to lower mortality, CVD risk in obese patients: Study Medha Baranwal9 March 2022 9:15 AM ISTThe Netherlands: Systematic review and meta-analysis of 39 controlled cohort studies revealed that bariatric surgery reduces the risk of all-cause and...
High-Sensitivity Troponin I Helps Identify Patients Who Need Revascularization post cardiac surgery MD Bureau3 March 2022 10:15 AM ISTIdentifying post-CABG myocardial infarction and the need for revascularization is challenging and requires the integration of various clinical...
Sodium in soluble paracetamol linked to increased risk of CVD Hina Zahid1 March 2022 9:45 AM ISTDoctors have warned that people should try to avoid taking dissolving, fizzy paracetamol that contains salt, following findings from a large study...
Pregnancy loss is associated with a greater CVD risk: Study Dr. Shravani Dali21 Feb 2022 9:00 AM ISTA history of pregnancy loss may be significantly linked with increased risk for future CVD, CHD and stroke, according to an analysis of the Nurses'...
Statin intolerance is "over-estimated and over-diagnosed" Hina Zahid18 Feb 2022 9:45 AM ISTAs many as one in two patients stop taking statins, reduce the dose or take them irregularly because they believe the cholesterol-lowering drugs cause...
Study Finds New Evidence on Personalized Selection of Antiplatelet Therapy MD Bureau3 Feb 2022 9:00 AM ISTOral P2Y12 inhibitors (clopidogrel, prasugrel, and ticagrelor) used in conjunction with aspirin constitute a key strategy for the prevention of...
Addition of anacetrapib to statins lowers coronary events in ASCVD: REVEAL trial Medha Baranwal31 Jan 2022 9:45 AM ISTUK: E Sammons, University of Oxford, Oxford, UK, and colleagues have found in a randomized controlled trial REVEAL that addition of cholesteryl...
Beta-blockers and RAAS inhibitors may prevent LVEF dysfunction due to breast cancer drugs: Study Medha Baranwal24 Jan 2022 11:00 AM ISTSweden: A meta-analysis suggests that beta-blockers (BBs) and angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (ACEI/ARBs) may...
Abnormal FFRCT test tied to recurrent chest pain: Study Medha Baranwal7 Jan 2022 9:00 AM ISTDenmark: An abnormal fractional flow reserve CT (FFRCT) test result in patients with new-onset stable angina pectoris (SAP) is associated with an...
Long Term Use Of Anacetrapib Reduces Major Coronary Events MD Bureau7 Jan 2022 9:00 AM ISTStudies have shown that inhibition of cholesteryl ester transfer protein (CETP) by anacetrapib reduces low-density lipoprotein (LDL) cholesterol...
Amphilimus-eluting stents tied to less target lesion failure in diabetics undergoing PCI: SUGAR Trial Medha Baranwal7 Jan 2022 9:00 AM ISTSpain: Amphilimus-eluting stents (AES) are superior to zotarolimus-eluting stents (ZES) with regards to target lesion and target vessel failure...
